Evidence map›Paper›PMID 28823934›Full record

ArticleNeurobiology of disease2017

Structural alterations in fast-spiking GABAergic interneurons in a model of posttraumatic neocortical epileptogenesis.

Feng Gu, Isabel Parada, Fran Shen, Judith Li, Alberto Bacci, Kevin Graber, Reza Moein Taghavi, Karina Scalise, Philip Schwartzkroin, Jurgen Wenzel and 1 more

Open access · greenAbstract read
In one paragraph

Article in Neurobiology of disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 34 citations in OpenAlex.

  1. Impairment of the GABAergic system in the prefrontal cortex of male heroin addicts.European archives of psychiatry and clinical neuroscience · 2026
    Article
  2. Impairment of the GABAergic system in the anterior midcingulate cortex of heroin-addicted males.European archives of psychiatry and clinical neuroscience · 2025
    Article
  3. Synaptic Vesicle Glycoprotein 2A Knockout in Parvalbumin and Somatostatin Interneurons Drives Seizures in the Postnatal Mouse Brain.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  4. Impairment of the GABAergic system in the anterior insular cortex of heroin-addicted males.European archives of psychiatry and clinical neuroscience · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Chronic partial TrkB activation reduces seizures and mortality in a mouse model of Dravet syndrome.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Antagonizing IncreasedThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Feng GuEpilepsy Research Laboratories, Stanford Univ. Sch. of Medicine, United States.
Isabel ParadaEpilepsy Research Laboratories, Stanford Univ. Sch. of Medicine, United States.
Fran ShenEpilepsy Research Laboratories, Stanford Univ. Sch. of Medicine, United States.
Judith LiEpilepsy Research Laboratories, Stanford Univ. Sch. of Medicine, United States.
Alberto BacciICM - Hôpital Pitié Salpêtrière, 7, bd de l'hôpital, 75013 Paris, France.
Kevin GraberEpilepsy Research Laboratories, Stanford Univ. Sch. of Medicine, United States.
Reza Moein TaghaviEpilepsy Research Laboratories, Stanford Univ. Sch. of Medicine, United States.
Karina ScaliseEpilepsy Research Laboratories, Stanford Univ. Sch. of Medicine, United States.
Philip SchwartzkroinDepartment of Neurological Surgery, University of California, Davis, United States.
Jurgen WenzelDepartment of Neurological Surgery, University of California, Davis, United States.
David A PrinceEpilepsy Research Laboratories, Stanford Univ. Sch. of Medicine, United States. Electronic address: daprince@stanford.edu.
Stanford University · USInstitut du Cerveau · FRNeurological Surgery · USUniversity of California, Davis · US

Funding

REGULATION OF NEURONAL EXCITABILITY IN CHRONIC EPILEPTOGENESISP50NS012151 · NINDS · STANFORD UNIVERSITY · PI HUGUENARD, JOHN R · 1985 to 2007
$9.1M
CELLULAR MECHANISMS IN FOCAL EPILEPTOGENESISR01NS006477 · NINDS · STANFORD UNIVERSITY · PI HUGUENARD, JOHN R · 1985 to 2013
$5.0M
Epilepsy Research ProgramP01NS012151 · NINDS · STANFORD UNIVERSITY · PI HUGUENARD, JOHN R · 2008 to 2011
$4.4M
MODULATION OF NEOCORTICAL INTERNEURONAL FUNCTIONR01NS039579 · NINDS · STANFORD UNIVERSITY · PI HUGUENARD, JOHN R, PRINCE, DAVID ALLAN · 2000 to 2013
$4.3M
Modulation of Neocortical Interneuronal FunctionR56NS039579 · NINDS · STANFORD UNIVERSITY · PI PRINCE, DAVID ALLAN · 2014 to 2014
$402k
NINDS NIH HHS P01 NS012151NINDS NIH HHS P50 NS012151NINDS NIH HHS R01 NS006477NINDS NIH HHS R01 NS039579NINDS NIH HHS R56 NS039579
6 · The paper itself

Abstract

Electrophysiological experiments in the partial cortical isolation ("undercut" or "UC") model of injury-induced neocortical epileptogenesis have shown alterations in GABAergic synaptic transmission attributable to abnormalities in presynaptic terminals. To determine whether the decreased inhibition was associated with structural abnormalities in GABAergic interneurons, we used immunocytochemical techniques, confocal microscopy and EM in UC and control sensorimotor rat cortex to analyze structural alterations in fast-spiking parvalbumin-containing interneurons and pyramidal (Pyr) cells of layer V. Principle findings were: 1) there were no decreases in counts of parvalbumin (PV)- or GABA-immunoreactive interneurons in UC cortex, however there were significant reductions in expression of VGAT and GAD-65 and -67 in halos of GABAergic terminals around Pyr somata in layer V. 2) Consistent with previous results, somatic size and density of Pyr cells was decreased in infragranular layers of UC cortex. 3) Dendrites of biocytin-filled FS interneurons were significantly decreased in volume. 4) There were decreases in the size and VGAT content of GABAergic boutons in axons of biocytin-filled FS cells in the UC, together with a decrease in colocalization with postsynaptic gephyrin, suggesting a reduction in GABAergic synapses. Quantitative EM of layer V Pyr somata confirmed the reduction in inhibitory synapses. 5) There were marked and lasting reductions in brain derived neurotrophic factor (BDNF)-IR and -mRNA in Pyr cells and decreased TrkB-IR on PV cells in UC cortex. 6) Results lead to the hypothesis that reduction in trophic support by BDNF derived from Pyr cells may contribute to the regressive changes in axonal terminals and dendrites of FS cells in the UC cortex and decreased GABAergic inhibition. SIGNIFICANCE: Injury to cortical structures is a major cause of epilepsy, accounting for about 20% of cases in the general population, with an incidence as high as ~50% among brain-injured personnel in wartime. Loss of GABAergic inhibitory interneurons is a significant pathophysiological factor associated with epileptogenesis following brain trauma and other etiologies. Results of these experiments show that the largest population of cortical interneurons, the parvalbumin-containing fast-spiking (FS) interneurons, are preserved in the partial neocortical isolation model of partial epilepsy. However, axonal terminals of these cells are structurally abnormal, have decreased content of GABA synthetic enzymes and vesicular GABA transporter and make fewer synapses onto pyramidal neurons. These structural abnormalities underlie defects in GABAergic neurotransmission that are a key pathophysiological factor in epileptogenesis found in electrophysiological experiments. BDNF, and its TrkB receptor, key factors for maintenance of interneurons and pyramidal neurons, are decreased in the injured cortex. Results suggest that supplying BDNF to the injured epileptogenic brain may reverse the structural and functional abnormalities in the parvalbumin FS interneurons and provide an antiepileptogenic therapy.

Indexed as

Action PotentialsAnimalsBrain-Derived Neurotrophic FactorDisease Models, AnimalEpilepsy, Post-TraumaticGABAergic NeuronsGlutamate DecarboxylaseImmunohistochemistryInterneuronsMaleMicroscopy, ConfocalMicroscopy, ElectronNeocortexParvalbuminsPyramidal CellsRats, Sprague-DawleyBrain-Derived Neurotrophic FactorGlutamate Decarboxylaseglutamate decarboxylase 1Ntrk2 protein, ratParvalbuminsReceptor, trkBRNA, MessengerSlc32a1 protein, ratSynaptophysinVesicular Inhibitory Amino Acid Transport ProteinsAxonal boutonsBDNFEpilepsyGABAInhibitory synapsesParvalbuminTraumatic injuryTrkBTrophic

Identifiers

PMID28823934
PMCPMC5927780
OpenAlexW2750127374

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.